Allarity Therapeutics, Inc. Revenue from Contract with Customer, Including Assessed Tax
Allarity Therapeutics, Inc. (ALLR) reported Revenue from Contract with Customer, Including Assessed Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-14
- Allarity Therapeutics, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2026-06-30 was $0.00.
- Allarity Therapeutics, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $25.00K.
- Allarity Therapeutics, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-06-30 was $0.00.
- Allarity Therapeutics, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-03-31 was $0.00.
- Allarity Therapeutics, Inc. revenue from contract with customer, including assessed tax for fiscal 2025 was $320.00K.
- Allarity Therapeutics, Inc. revenue from contract with customer, including assessed tax for fiscal 2024 was $0.00.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $25.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $25.00K 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | $320.00K 10-K · filed 2026-03-30 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |